The monoclonal antibody Myc 1-6E10 was used in an immunocytochemical technique to examine the expression of the c-myc oncogene in normal endocervices and those with glandular intraepithelial neoplasia and invasive malignancy. Eleven 
The incidence of adenocarcinoma of the uterine cervix in women under 30 years of age has increased in the past 10 years, both in absolute terms' and in the proportion of total cervical malignancies that these tumours comprise.2' The natural history of these tumours has been less well investigated than that of their squamous counterparts. Although some evidence suggests that adenocarcinoma at this site can arise de novo,4 this might be explained by the underdiagnosis of in situ lesions.56 The terminology used for such in situ lesions is somewhat confusing. We have chosen to use the term glandular intraepithelial neoplasia (GIN), and to subdivide these histologically into low or high grade lesions. Others use the term cervical glandular atypia; these lesions are also subdivided into low or high grade, the latter alternatively referred to as adenocarcinoma in situ. 7 The biological behaviour of GIN remains unclear and the diagnosis of such lesions difficult. These difficulties conspire to make the clinical follow up of cases problematical.
The diagnostic use of immunocytochemistry in this area has been little studied. Antiepithelial membrane antigen staining is identical in high grade glandular intraepithelial neoplasia and invasive adenocarcinoma,' but differential expression of human milk fat globulin antigen in GIN and the normal endocervix does seem to occur.9 Other markers have also been studied, including those directed against intermediate filaments and carcinoembryonic antigen.'0 An attempt has been made to correlate silver nucleolar organiser region (AgNor) counts in GIN and invasive adenocarcinoma. " The examination of oncogene expression in a variety of malignant and pre-malignant states has proved to be of variable diagnostic use. Oncogenes are highly conserved regions of the normal genome. A change in the coding or controlling regions of these genes has been implicated in the pathogenesis of neoplasia. The human c-myc oncogene is the cellular homologue of the avian v-myc gene found in some leukaemogenic retroviruses. The gene has been shown to have an important role in early embryogenesis,'2 the control of cell growth,'3 cellular differentiation4' 5 land), diluted 1 in 10 000 in TRIS-buffered saline with 1% bovine serum albumin and 0-25% Triton X-100 (pH 7-3). After further washing, biotinylated sheep anti-mouse immunoglobulin was applied to the sections at a dilution of 1 in 100 and incubated for 60 minutes. After additional washes, incubation in Vectostain ABC reagent (Vector Laboratories, England) was performed for one hour, followed by a final incubation in diaminobenzidine (100 mg in 100 ml 0-5% hydrogen peroxide solution) for 10 minutes. The sections were washed in tap water and counterstained in Harris's haematoxylin for 60 seconds.
All washes, unless specifically stated, were performed using TRIS-buffered saline containing 1% bovine sefum albumin, and incubations were at room temperature.
The specificity of Myc-1-6E10 has been investigated and its immunoreactivity found to be annulled by addition of the peptide used as immunogen in the production of the antibody. 24 Results Of the 14 normal endocervical specimens, 11
cases were completely unstained, indicating that c-myc oncogene was not expressed (fig 1) . Three cases showed weak positive staining of the nucleus, and of these, two cases showed additional weak positive staining of the basal cytoplasm. In none of these cases was positive staining of the apical cell cytoplasm shown (table 1). "Normal" glands concurrent with GIN 12 9 6 0 "Normal" glands concurrent with 9 9 6 0 adenocarcinoma All but one of the 14 cases of low and high grade GIN showed pan-cellular c-myc distribution, with weak positive staining ofthe cell nucleus, together with positivity of the basal and apical cell cytoplasm (fig 2) . There was no distinction, based on the cellular distribution of protein, between low and high grade GIN, although the single non-staining case was histologically low grade.
All 17 cases of invasive endocervical carcinoma showed a pan-cellular distribution of cmyc (fig 3) . There was no difference in cellular distribution between tumours of varying degrees of differentiation, but poorly differentiated tumours tended to stain less intensely than better differentiated tumours. This may represent a lower level of gene expression in these tumours, but no formal attempt has been made to quantify the concentrations of myc proteins in these tumours.
Of particular interest to us was the staining pattern observed in morphologically normal endocervical glands adjacent to areas of glandular intraepithelial neoplasia or carcinoma. Of 12 cases (out of the original 14) of GIN, in which morphologically normal glands were included in the tissue section, nine cases showed positive nuclear staining (fig 4) , and of these, six showed additional positive basal cytoplasmic staining (table 2) . This staining pattern was seen in those with both low and high grade GIN elsewhere in the biopsy specimen. Nine of the cases of invasive adenocarcinoma included morphologically normal endocervical glands in the same tissue section. All nine cases showed positive nuclear staining, and six of these showed basal cytoplasmic staining ( It is against this confused background that our own results are presented. We have shown substantial expression of the c-myc gene in glandular intraepithelial neoplasia and in malignant endocervical cells. Furthermore, myc immunostaining seemed to be a powerful discriminator between normal cervical glandular epithelium and epithelium showing intraepithelial changes or overt malignant change.
Normal endocervical epithelial tissues showed only very occasional evidence of myc expression, and in no instance was staining of the apical cell cytoplasm observed. Epithelial tissues showing glandular intraepithelial neoplasia or malignant change invariably expressed the myc gene, with a pan-cellular distribution of myc product. Apical cytoplasmic myc localisation thus seemed to be specific for GIN and invasive adenocarcinoma at this site, and myc expression alone was strongly correlated with such changes in cell phenotype.
These features may be of diagnostic value in distinguishing low grade glandular intraepithelial neoplasia from normal epithelium, although the clinical importance of such low grade lesions is as yet imprecisely defined.7
Immunostaining for myc proteins does not permit discrimination between glandular intraepithelial neoplasia and malignancy, or between low and high grade GIN. The pattern of staining in all these conditions is identical, with a pan-cellular distribution of myc protein.
In addition to the expected nuclear siting of myc protein, we have shown considerable location of myc product in the endocervical cell cytoplasm. This 
